Prescription drug · NDA
Blood Collection System (Cp2d/as-3 triple with sampling system) NDC 87069-121
Dextrose, Unspecified form 3.57 g/70mL · Solution · Intravenous · GVS TM INC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 87069-121-63 | 87069012163 | 8 POUCH in 1 CARTON (87069-121-63) / 3 BAG in 1 POUCH / 70 mL in 1 BAGMarketed from Jun 23, 2026 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Blood Collection System
- Generic name (nonproprietary)
- cp2d/as-3 triple with sampling system
- Active ingredients
- Dextrose, Unspecified form — 3.57 g/70mL
- Dosage form
- Solution
- Route
- Intravenous
- Labeler
- GVS TM INCNDC labeler code 87069
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication BN 820915
- Marketing start
- Listing expires
- Identifiers
- Product ID 87069-121_54e8cfd2-f91c-8381-e063-6394a90a3f77SPL ID 54e8cfd2-f91c-8381-e063-6394a90a3f77SPL set ID 54e8cfd2-f91b-8381-e063-6394a90a3f77UNII IY9XDZ35W2
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N487069012163followed by a unit qualifier and the quantityPackage 87069-0121-63. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
About NDC 87069-121
- What is NDC 87069-121?
- 87069-121 is the product NDC for Blood Collection System (cp2d/as-3 triple with sampling system), Dextrose, Unspecified form 3.57 g/70mL solution, listed with the FDA by GVS TM INC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Blood Collection System (CP2D/AS-3 triple with sampling system).
- What is the active ingredient?
- Dextrose, Unspecified form.
- Who is the labeler?
- GVS TM INC, NDC labeler code 87069. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Blood Collection System?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Other NDCs under BN 820915
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Leukotrap RC PL Systemcp2d/as-3 anticoagulant and additive system | Dextrose, Unspecified form 3.57 g/70mL | SolutionIntravenous | GVS TM INC | 87069-123 |
| Leukotrap WB System - CP2Dcp2d/as-3 - anticoagulant and additive system | Dextrose, Unspecified form 3.57 g/70mL | SolutionIntravenous | GVS TM INC | 87069-126 |
| Leukotrap RC PL Systemcp2d/as-3 anticoagulant and additive system | Dextrose, Unspecified form 3.57 g/70mL | SolutionIntravenous | GVS TM INC | 87069-123 |
| Leukotrap RC PL Systemcp2d/as-3 anticoagulant and additive system | Dextrose, Unspecified form 3.57 g/70mL | SolutionIntravenous | GVS TM INC | 87069-123 |
| Leukotrap WB System - CP2Dcp2d/as-3 - anticoagulant and additive system | Dextrose, Unspecified form 3.57 g/70mL | SolutionIntravenous | GVS TM INC | 87069-126 |
| Leukotrap RC Systemcp2d/as-3 anticoagulant and additive system | Dextrose, Unspecified form 3.57 g/70mL | SolutionIntravenous | GVS TM INC | 87069-129 |
| Leukotrap RC Systemcp2d/as-3 anticoagulant and additive system | Dextrose, Unspecified form 3.57 g/70mL | SolutionIntravenous | GVS TM INC | 87069-129 |
| Leukotrap RC Systemcp2d/as-3 anticoagulant and additive system | Dextrose, Unspecified form 3.57 g/70mL | SolutionIntravenous | GVS TM INC | 87069-129 |
| Cp2D | Dextrose, Unspecified form 4.64 g/100mL | SolutionIntravenous | GVS TM INC | 87069-455 |
| Leukotrap WB system - CP2Dcp2d/as-3 anticoagulant and additive system | Dextrose, Unspecified form 3.21 g/63mL | SolutionIntravenous | GVS TM INC | 87069-726 |
| As-3 | Adenine .03 g/100mL; Dextrose, Unspecified form 1 g/100mL | SolutionIntravenous | GVS TM INC | 87069-460 |
| As-3 | Adenine .03 g/100mL; Dextrose, Unspecified form 1 g/100mL | SolutionIntravenous | GVS TM INC | 87069-462 |
| Leukotrap WB system - CP2Dcp2d/as-3 anticoagulant and additive system | Dextrose, Unspecified form 3.21 g/63mL | SolutionIntravenous | GVS TM INC | 87069-726 |